120 related articles for article (PubMed ID: 37953124)
1. Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study.
Gatselis NK; Lyberopoulou A; Lygoura V; Giannoulis G; Samakidou A; Vaiou A; Antoniou K; Triantafyllou K; Stefos A; Georgiadou S; Sagris D; Sveroni D; Gabeta S; Ntaios G; Norman GL; Dalekos GN
Eur J Intern Med; 2024 Apr; 122():78-85. PubMed ID: 37953124
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study).
García de Guadiana-Romualdo L; Rodríguez Rojas C; Morell-García D; Andaluz-Ojeda D; Rodríguez Mulero MD; Rodríguez-Borja E; Ballesteros-Vizoso A; Calvo MD; Albert-Botella L; Pozo Giráldez A; Llompart-Alabern I; Bolado Jiménez C; Hernández Olivo M; Fernández Presa L; Ortega-Pérez J; Fora Romero MJ; Campos-Rodríguez V; Ballester Férriz A; Guiu-Martí AM; Pinilla Arribas L; Galindo Martínez M; Puerto-Lara ER; López Tarazaga AB; Ros Braquehais MS; Nogales Martín L; Juez Santamaría C; Trapiello Fernández W; Espinilla Fernández V; Havelka A; Albaladejo-Otón MD
Inflamm Res; 2022 Jan; 71(1):57-67. PubMed ID: 34718856
[TBL] [Abstract][Full Text] [Related]
3. Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients.
Gatselis NK; Lygoura V; Lyberopoulou A; Giannoulis G; Samakidou A; Vaiou A; Vatidis G; Antoniou K; Stefos A; Georgiadou S; Sagris D; Sveroni D; Stergioula D; Gabeta S; Ntaios G; Dalekos GN
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458517
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients.
Chapuis N; Ibrahimi N; Belmondo T; Goulvestre C; Berger AE; Mariaggi AA; Andrieu M; Chenevier-Gobeaux C; Bayle A; Campos L; Cheurfa C; Chocron R; Diehl JL; Doumenc B; Duchemin J; Duprat M; François F; Gendron N; Mirault T; Pène F; Philippe A; Pommeret F; Sanchez O; Smadja DM; Szwebel TA; Silvin A; Ginhoux F; Lacroix L; Jules-Clément G; Rapeteramana S; Mavier C; Steller L; Perniconi B; André F; Drubay D; Fontenay M; Hüe S; Paul S; Solary E
EBioMedicine; 2022 Jun; 80():104077. PubMed ID: 35644124
[TBL] [Abstract][Full Text] [Related]
5. Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19.
Ducastel M; Chenevier-Gobeaux C; Ballaa Y; Meritet JF; Brack M; Chapuis N; Pene F; Carlier N; Szwebel TA; Roche N; Terrier B; Borderie D
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299080
[TBL] [Abstract][Full Text] [Related]
6. Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19.
Lee A; Nahm CH; Lee JS; Lee MK; Lee KR
J Clin Lab Anal; 2021 Nov; 35(11):e24004. PubMed ID: 34608677
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: An Italian study.
Infantino M; Manfredi M; Alessio MG; Previtali G; Grossi V; Benucci M; Faraone A; Fortini A; Grifoni E; Masotti L; Russo E; Amedei A; FitzGerald E; Albesa R; Norman GL; Mahler M
J Med Virol; 2022 Dec; 94(12):5758-5765. PubMed ID: 35941084
[TBL] [Abstract][Full Text] [Related]
8. Serum calprotectin can indicate current and future severity of COVID-19.
Shokri-Afra H; Moradi M; Musavi H; Moradi-Sardareh H; Moradi Poodeh B; Kazemi Veisari A; Oladi Z; Ebrahimi M
J Clin Lab Anal; 2023 Jan; 37(1):e24809. PubMed ID: 36525302
[TBL] [Abstract][Full Text] [Related]
9. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
[TBL] [Abstract][Full Text] [Related]
10. Measurement of calprotectin in ascitic fluid to identify elevated polymorphonuclear cell count.
Burri E; Schulte F; Muser J; Meier R; Beglinger C
World J Gastroenterol; 2013 Apr; 19(13):2028-36. PubMed ID: 23599621
[TBL] [Abstract][Full Text] [Related]
11. Serum calprotectin as a novel biomarker for severity of COVID-19 disease.
Kaya T; Yaylacı S; Nalbant A; Yıldırım İ; Kocayiğit H; Çokluk E; Şekeroğlu MR; Köroğlu M; Güçlü E
Ir J Med Sci; 2022 Feb; 191(1):59-64. PubMed ID: 33641087
[TBL] [Abstract][Full Text] [Related]
12. Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study.
Inciarte-Mundo J; Ramirez J; Hernández MV; Ruiz-Esquide V; Cuervo A; Cabrera-Villalba SR; Pascal M; Yagüe J; Cañete JD; Sanmarti R
Arthritis Res Ther; 2018 Dec; 20(1):275. PubMed ID: 30545393
[TBL] [Abstract][Full Text] [Related]
13. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
Kostas A; Siakavellas SI; Kosmidis C; Takou A; Nikou J; Maropoulos G; Vlachogiannakos J; Papatheodoridis GV; Papaconstantinou I; Bamias G
World J Gastroenterol; 2017 Nov; 23(41):7387-7396. PubMed ID: 29151692
[TBL] [Abstract][Full Text] [Related]
14. Association of calprotectin with other inflammatory parameters in the prediction of mortality for ischemic stroke.
Marta-Enguita J; Navarro-Oviedo M; Rubio-Baines I; Aymerich N; Herrera M; Zandio B; Mayor S; Rodriguez JA; Páramo JA; Toledo E; Mendioroz M; Muñoz R; Orbe J
J Neuroinflammation; 2021 Jan; 18(1):3. PubMed ID: 33402185
[TBL] [Abstract][Full Text] [Related]
15. Association Between Level of Fecal Calprotectin and Progression of Crohn's Disease.
Kennedy NA; Jones GR; Plevris N; Patenden R; Arnott ID; Lees CW
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2269-2276.e4. PubMed ID: 30772585
[TBL] [Abstract][Full Text] [Related]
16. Elevated level of circulating calprotectin correlates with severity and high mortality in patients with COVID-19.
Zhang H; Zhang Q; Liu K; Yuan Z; Xu X; Dong J
Immun Inflamm Dis; 2024 Mar; 12(3):e1212. PubMed ID: 38477671
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil calprotectin identifies severe pulmonary disease in COVID-19.
Shi H; Zuo Y; Yalavarthi S; Gockman K; Zuo M; Madison JA; Blair C; Woodward W; Lezak SP; Lugogo NL; Woods RJ; Lood C; Knight JS; Kanthi Y
J Leukoc Biol; 2021 Jan; 109(1):67-72. PubMed ID: 32869342
[TBL] [Abstract][Full Text] [Related]
18. Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study.
Manz M; Burri E; Rothen C; Tchanguizi N; Niederberger C; Rossi L; Beglinger C; Lehmann FS
BMC Gastroenterol; 2012 Jan; 12():5. PubMed ID: 22233279
[TBL] [Abstract][Full Text] [Related]
19. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
[TBL] [Abstract][Full Text] [Related]
20. Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn's disease patients.
Foster AJ; Smyth M; Lakhani A; Jung B; Brant RF; Jacobson K
World J Gastroenterol; 2019 Mar; 25(10):1266-1277. PubMed ID: 30886509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
